Get the Stockscreener App
2.46
1.60%
-0.04
After Hours:
2.49
0.03
+1.22%
Medicus Pharma Ltd stock is traded at $2.46, with a volume of 248.73K.
It is down -1.60% in the last 24 hours and down -17.73% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.50
Open:
$2.49
24h Volume:
248.73K
Relative Volume:
0.65
Market Cap:
$41.06M
Revenue:
-
Net Income/Loss:
$-11.73M
P/E Ratio:
-1.7793
EPS:
-1.3826
Net Cash Flow:
$-10.37M
1W Performance:
-18.54%
1M Performance:
-17.73%
6M Performance:
-5.38%
1Y Performance:
+0.00%
1-Day Range:
$2.42
$2.56
1-Week Range:
$2.3815
$3.06
52-Week Range:
$1.80
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.46 | 41.06M | 0 | -11.73M | -10.37M | -1.3826 |
|
LLY
Lilly Eli Co
|
740.07 | 682.35B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
164.74 | 402.82B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
189.02 | 334.40B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
113.74 | 225.78B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
78.12 | 205.28B | 63.62B | 16.41B | 17.04B | 6.49 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Is Medicus Pharma Ltd. a growth stock or a value stockSwing Trade Forecasts For Smart Trading - jammulinksnews.com
What institutional investors are buying Medicus Pharma Ltd. stockStock Strategy Signals For Consistent Profits - jammulinksnews.com
What are Medicus Pharma Ltd. Equity Warrant company’s key revenue driversWealth Building Signals From AI Tools - jammulinksnews.com
What are the technical indicators suggesting about Medicus Pharma Ltd.Advanced Screener Ideas For Fast Growth - jammulinksnews.com
How Medicus Pharma Ltd. stock performs during market volatilityExpert Verified Stock Trade Ideas Backed by Data - metal.it
Published on: 2025-07-30 18:35:25 - metal.it
Medicus Pharma Appoints Deloitte for Licensing Deal - TipRanks
Medicus Pharma appoints Deloitte as adviser for potential D-MNA out-licensing - Investing.com Nigeria
Watch for Bullish Crossover in Medicus Pharma Ltd.Momentum Based Equity Trading Plans Reviewed - metal.it
Published on: 2025-07-29 19:40:11 - metal.it
Why Medicus Pharma Ltd. stock attracts strong analyst attentionDaily Momentum Screener With Alerts Launched - beatles.ru
Why Medicus Pharma Ltd. Equity Warrant stock attracts strong analyst attentionCapital Preserving Trade Plan Templates Shared - metal.it
RSI Suggests Rebound May Be Near in Medicus Pharma Ltd. Equity Warrant - metal.it
When is Medicus Pharma Ltd. stock expected to show significant growthEntry Signal Growth Plan For Smart Trading - jammulinksnews.com
How does Medicus Pharma Ltd. Equity Warrant compare to its industry peersWealth Building Trend Scanner For Smart Trading - jammulinksnews.com
Why is Medicus Pharma Ltd. Equity Warrant stock attracting strong analyst attentionFast-track wealth growth - jammulinksnews.com
Should I hold or sell Medicus Pharma Ltd. stock in 2025Earnings Report Alerts For Every Investor - jammulinksnews.com
How many analysts rate Medicus Pharma Ltd. as a “Buy”Capitalize on fast-moving stock opportunities - jammulinksnews.com
Is it the right time to buy Medicus Pharma Ltd. Equity Warrant stockFree Stock Market Query - jammulinksnews.com
Is Medicus Pharma Ltd. Equity Warrant stock overvalued or undervaluedSuperior capital gains - jammulinksnews.com
What is Medicus Pharma Ltd. company’s growth strategyTrack top-performing stocks in real-time - jammulinksnews.com
Buy Signal for Medicus Pharma Ltd. Stock Key Technical Indicators to WatchLow Drawdown Trade Signals - metal.it
How volatile is Medicus Pharma Ltd. Equity Warrant stock compared to the marketUnlock steady growth with low-risk stocks - jammulinksnews.com
Is it the right time to buy Medicus Pharma Ltd. stockTremendous wealth creation - jammulinksnews.com
What makes Medicus Pharma Ltd. Equity Warrant stock price move sharplyInvest confidently with advanced analysis tools - jammulinksnews.com
What institutional investors are buying Medicus Pharma Ltd. Equity Warrant stockRecord-setting profit potential - jammulinksnews.com
Medicus Pharma Ltd. Company’s Quarterly Earnings Growth: What the Numbers SayMassive Gain Ideas - metal.it
Intrinsic Value of Medicus Pharma Ltd. Equity Warrant Stock: Is It Undervalued or OvervaluedProven Return Strategy Execution - metal.it
What makes Medicus Pharma Ltd. stock price move sharplyProven Win Setups - metal.it
What drives Medicus Pharma Ltd. stock priceRapid-fire capital growth - PrintWeekIndia
Medicus Pharma to acquire Antev for $75M in share exchange transaction - MSN
Medicus Pharma Ltd. Stock Analysis and ForecastOutstanding yields - Autocar Professional
What analysts say about Medicus Pharma Ltd. stock outlookFree Trading Psychology Coaching - jammulinksnews.com
Should I buy Medicus Pharma Ltd. stock before earningsHigh-velocity gains - jammulinksnews.com
What analysts say about Medicus Pharma Ltd. Equity Warrant stockDynamic profit expansion - Autocar Professional
Is Medicus Pharma Ltd. Equity Warrant a good long term investmentExplosive capital gains - PrintWeekIndia
MDCX Form 4: CFO receives 50k options at $3.08, now holds 70k | VIV SEC FilingForm 6-K - Stock Titan
What drives Medicus Pharma Ltd. Equity Warrant stock priceFree Stock Selection - PrintWeekIndia
Is Medicus Pharma Ltd. a good long term investmentUnprecedented profit potential - jammulinksnews.com
Medicus Pharma shareholders approve new board members and FDA submission for Skin Cancer therapy - Proactive financial news
Medicus Pharma Ltd. Equity Warrant Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):